About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Michigan | 904 Studies

Clinical Trials Breast CancerMichigan

Breast Cancer Clinical Trials in Michigan

Find 904 clinical trials for breast cancer near Michigan. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Michigan

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 221-240 of 904 trials

CompletedPrognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast CancerRATIONALE: Biopsy of sentinel lymph nodes and bone marrow may improve the ability to detect and determine the extent of cancer.NCT00003854·Birmingham, Alabama and 115 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Study to Investigate APL-5125 in Adults With Advanced Solid TumorsThis is an open-label, Phase 1/2 study to determine the safety, tolerability, and efficacy of APL-5125 for the treatment of selected locally advanced or metastatic solid tumors…NCT06399757·Duarte, California and 8 others

RecruitingEvexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast CancerThis is a Phase 1b/2, open-label, parallel-arms pilot study in men and post-menopausal women with hormone receptor positive (HR+), HER2- advanced or metastatic breast cancer with…NCT05455619·Loma Linda, California and 9 others

Active not recruitingTesting Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast CancerThis Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive…NCT05705401·Phoenix, Arizona and 417 others

Active not recruitingUnderstanding and Predicting Breast Cancer Events After TreatmentThis study is being done to see if patients receiving chemotherapy for breast cancer affects the heart, the ability to exercise and fatigue when compared to patients who do not…NCT02791581·Birmingham, Alabama and 65 others

CompletedOral Health in Breast Cancer Survivors on Aromatase InhibitorsThe purpose of this study is to determine how aromatase inhibitors (AIs) such as Arimidex, Aromasin or Femara affect a woman's oral health and oral health related quality of life.NCT01693731·Ann Arbor, Michigan

CompletedDoxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast CancerThis randomized phase III trial studies doxorubicin hydrochloride, cyclophosphamide, paclitaxel, and trastuzumab to see how well they work compared to combination chemotherapy…NCT00005970·Birmingham, Alabama and 156 others

CompletedPaclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by SurgeryThis randomized phase II trial studies how well paclitaxel with or without carboplatin and/or bevacizumab followed by doxorubicin and cyclophosphamide works in treating patients…NCT00861705·Jonesboro, Arkansas and 447 others

TerminatedMycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)RATIONALE: Mycophenolate mofetil added to immunosuppressive treatment regimens may be effective in treating newly diagnosed chronic graft-versus-host disease caused by stem cell…NCT00089141·Duarte, California and 15 others

CompletedLEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)The purpose of this signal seeking study was to determine whether treatment with LEE011 demonstrates sufficient efficacy in CDK4/6 pathway activated solid tumors and/or…NCT02187783·Birmingham, Alabama and 60 others

CompletedTissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast CancerThis study is being performed so that tumor and blood samples from patients who will receive breast cancer treatment prior to surgery can be collected and stored for future…NCT00161265·Ann Arbor, Michigan

CompletedSurgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast CancerRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00881361·Mobile, Alabama and 323 others

TerminatedPhase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous PaclitaxelDetermine the safety, tolerability, maximum tolerated dose (MTD), and recommended Phase II dose (RP2D) of BAY1161909 in combination with paclitaxel in subjects with advanced…NCT02138812·Santa Monica, California and 5 others

CompletedRadiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast CancerRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Giving radiation therapy in different ways may kill any tumor cells that remain after surgery.NCT00103181·Birmingham, Alabama and 386 others

CompletedAvoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision AidThe aim of this study is to learn whether participants find a patient guide to breast cancer treatment decisions acceptable and appropriate for use.NCT05140252·Ann Arbor, Michigan

Active not recruitingOP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerThis phase 3 clinical trial compares the safety and efficacy of palazestrant (OP-1250) to the standard-of-care options of fulvestrant or an aromatase inhibitor in women and men…NCT06016738·Tucson, Arizona and 232 others

Active not recruiting(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast CancerThis open-label research study is studying (Z)-endoxifen as a possible treatment for pre-menopausal women with ER+/HER2- breast cancer.NCT05607004·Phoenix, Arizona and 13 others

Active not recruitingPhase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast CancerThe purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer.NCT04115306·Gilbert, Arizona and 9 others

CompletedCombination Chemotherapy in Treating Patients With Breast CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003088·Scottsdale, Arizona and 18 others

CompletedStudy of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)The purpose of this study is to evaluate the efficacy and safety of pembrolizumab (MK-3475) plus chemotherapy vs placebo plus chemotherapy as neoadjuvant therapy and pembrolizumab…NCT03036488·Scottsdale, Arizona and 192 others

PreviousPage 12 of 46Next

Other Conditions in Michigan

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma